Novartis’ latest settlements: $729M in kickback charges

Pharmaceuticals

A week after resolving FCPA investigations for $347 million, Swiss pharmaceutical drug maker Novartis will pay another $729 million in separate settlements related to kickback schemes.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.